Alkem reports 17% revenue growth and 22% growth in EBIDTA in Q2 FY26.
AHMEDABAD, November 14: Alkem Laboratories Ltd. today announced its standalone and consolidated financial results for the second quarter ended September 30, 2025. The Board of Directors took record of these results at its meeting held in Mumbai today. Key Financial Metrics Key highlights of Q2 FY26 financial performance Operational Highlights Domestic Business – Q2 FY26…